Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD86 Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global CD86 Antibody Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Enzyme Linked Immunosorbent Assay
1.3.3 Flow Cytometry
1.3.4 Immunohistochemistry
1.3.5 Western Blot
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD86 Antibody Market Perspective (2018-2029)
2.2 CD86 Antibody Growth Trends by Region
2.2.1 Global CD86 Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CD86 Antibody Historic Market Size by Region (2018-2024)
2.2.3 CD86 Antibody Forecasted Market Size by Region (2024-2029)
2.3 CD86 Antibody Market Dynamics
2.3.1 CD86 Antibody Industry Trends
2.3.2 CD86 Antibody Market Drivers
2.3.3 CD86 Antibody Market Challenges
2.3.4 CD86 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD86 Antibody Players by Revenue
3.1.1 Global Top CD86 Antibody Players by Revenue (2018-2024)
3.1.2 Global CD86 Antibody Revenue Market Share by Players (2018-2024)
3.2 Global CD86 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CD86 Antibody Revenue
3.4 Global CD86 Antibody Market Concentration Ratio
3.4.1 Global CD86 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD86 Antibody Revenue in 2022
3.5 CD86 Antibody Key Players Head office and Area Served
3.6 Key Players CD86 Antibody Product Solution and Service
3.7 Date of Enter into CD86 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CD86 Antibody Breakdown Data by Type
4.1 Global CD86 Antibody Historic Market Size by Type (2018-2024)
4.2 Global CD86 Antibody Forecasted Market Size by Type (2024-2029)
5 CD86 Antibody Breakdown Data by Application
5.1 Global CD86 Antibody Historic Market Size by Application (2018-2024)
5.2 Global CD86 Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CD86 Antibody Market Size (2018-2029)
6.2 North America CD86 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CD86 Antibody Market Size by Country (2018-2024)
6.4 North America CD86 Antibody Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD86 Antibody Market Size (2018-2029)
7.2 Europe CD86 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CD86 Antibody Market Size by Country (2018-2024)
7.4 Europe CD86 Antibody Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD86 Antibody Market Size (2018-2029)
8.2 Asia-Pacific CD86 Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CD86 Antibody Market Size by Region (2018-2024)
8.4 Asia-Pacific CD86 Antibody Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD86 Antibody Market Size (2018-2029)
9.2 Latin America CD86 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CD86 Antibody Market Size by Country (2018-2024)
9.4 Latin America CD86 Antibody Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD86 Antibody Market Size (2018-2029)
10.2 Middle East & Africa CD86 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CD86 Antibody Market Size by Country (2018-2024)
10.4 Middle East & Africa CD86 Antibody Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioLegend
11.1.1 BioLegend Company Detail
11.1.2 BioLegend Business Overview
11.1.3 BioLegend CD86 Antibody Introduction
11.1.4 BioLegend Revenue in CD86 Antibody Business (2018-2024)
11.1.5 BioLegend Recent Development
11.2 Proteintech
11.2.1 Proteintech Company Detail
11.2.2 Proteintech Business Overview
11.2.3 Proteintech CD86 Antibody Introduction
11.2.4 Proteintech Revenue in CD86 Antibody Business (2018-2024)
11.2.5 Proteintech Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific CD86 Antibody Introduction
11.3.4 Thermo Fisher Scientific Revenue in CD86 Antibody Business (2018-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Detail
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad CD86 Antibody Introduction
11.4.4 Bio-Rad Revenue in CD86 Antibody Business (2018-2024)
11.4.5 Bio-Rad Recent Development
11.5 FineTest
11.5.1 FineTest Company Detail
11.5.2 FineTest Business Overview
11.5.3 FineTest CD86 Antibody Introduction
11.5.4 FineTest Revenue in CD86 Antibody Business (2018-2024)
11.5.5 FineTest Recent Development
11.6 Miltenyi Biotec
11.6.1 Miltenyi Biotec Company Detail
11.6.2 Miltenyi Biotec Business Overview
11.6.3 Miltenyi Biotec CD86 Antibody Introduction
11.6.4 Miltenyi Biotec Revenue in CD86 Antibody Business (2018-2024)
11.6.5 Miltenyi Biotec Recent Development
11.7 Santa Cruz Biotechnology
11.7.1 Santa Cruz Biotechnology Company Detail
11.7.2 Santa Cruz Biotechnology Business Overview
11.7.3 Santa Cruz Biotechnology CD86 Antibody Introduction
11.7.4 Santa Cruz Biotechnology Revenue in CD86 Antibody Business (2018-2024)
11.7.5 Santa Cruz Biotechnology Recent Development
11.8 Bethyl
11.8.1 Bethyl Company Detail
11.8.2 Bethyl Business Overview
11.8.3 Bethyl CD86 Antibody Introduction
11.8.4 Bethyl Revenue in CD86 Antibody Business (2018-2024)
11.8.5 Bethyl Recent Development
11.9 United States Biological
11.9.1 United States Biological Company Detail
11.9.2 United States Biological Business Overview
11.9.3 United States Biological CD86 Antibody Introduction
11.9.4 United States Biological Revenue in CD86 Antibody Business (2018-2024)
11.9.5 United States Biological Recent Development
11.10 ProSci
11.10.1 ProSci Company Detail
11.10.2 ProSci Business Overview
11.10.3 ProSci CD86 Antibody Introduction
11.10.4 ProSci Revenue in CD86 Antibody Business (2018-2024)
11.10.5 ProSci Recent Development
11.11 Bio X Cell
11.11.1 Bio X Cell Company Detail
11.11.2 Bio X Cell Business Overview
11.11.3 Bio X Cell CD86 Antibody Introduction
11.11.4 Bio X Cell Revenue in CD86 Antibody Business (2018-2024)
11.11.5 Bio X Cell Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Detail
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter CD86 Antibody Introduction
11.12.4 Beckman Coulter Revenue in CD86 Antibody Business (2018-2024)
11.12.5 Beckman Coulter Recent Development
11.13 NSJ Bioreagents
11.13.1 NSJ Bioreagents Company Detail
11.13.2 NSJ Bioreagents Business Overview
11.13.3 NSJ Bioreagents CD86 Antibody Introduction
11.13.4 NSJ Bioreagents Revenue in CD86 Antibody Business (2018-2024)
11.13.5 NSJ Bioreagents Recent Development
11.14 EXBIO
11.14.1 EXBIO Company Detail
11.14.2 EXBIO Business Overview
11.14.3 EXBIO CD86 Antibody Introduction
11.14.4 EXBIO Revenue in CD86 Antibody Business (2018-2024)
11.14.5 EXBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CD86 Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global CD86 Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global CD86 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CD86 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CD86 Antibody Market Share by Region (2018-2024)
Table 8. Global CD86 Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CD86 Antibody Market Share by Region (2024-2029)
Table 10. CD86 Antibody Market Trends
Table 11. CD86 Antibody Market Drivers
Table 12. CD86 Antibody Market Challenges
Table 13. CD86 Antibody Market Restraints
Table 14. Global CD86 Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CD86 Antibody Market Share by Players (2018-2024)
Table 16. Global Top CD86 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD86 Antibody as of 2022)
Table 17. Ranking of Global Top CD86 Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by CD86 Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CD86 Antibody Product Solution and Service
Table 21. Date of Enter into CD86 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD86 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CD86 Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global CD86 Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CD86 Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global CD86 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CD86 Antibody Revenue Market Share by Application (2018-2024)
Table 29. Global CD86 Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CD86 Antibody Revenue Market Share by Application (2024-2029)
Table 31. North America CD86 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America CD86 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America CD86 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe CD86 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe CD86 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe CD86 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific CD86 Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific CD86 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific CD86 Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America CD86 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America CD86 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America CD86 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa CD86 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa CD86 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa CD86 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 46. BioLegend Company Detail
Table 47. BioLegend Business Overview
Table 48. BioLegend CD86 Antibody Product
Table 49. BioLegend Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 50. BioLegend Recent Development
Table 51. Proteintech Company Detail
Table 52. Proteintech Business Overview
Table 53. Proteintech CD86 Antibody Product
Table 54. Proteintech Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 55. Proteintech Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific CD86 Antibody Product
Table 59. Thermo Fisher Scientific Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Bio-Rad Company Detail
Table 62. Bio-Rad Business Overview
Table 63. Bio-Rad CD86 Antibody Product
Table 64. Bio-Rad Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 65. Bio-Rad Recent Development
Table 66. FineTest Company Detail
Table 67. FineTest Business Overview
Table 68. FineTest CD86 Antibody Product
Table 69. FineTest Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 70. FineTest Recent Development
Table 71. Miltenyi Biotec Company Detail
Table 72. Miltenyi Biotec Business Overview
Table 73. Miltenyi Biotec CD86 Antibody Product
Table 74. Miltenyi Biotec Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 75. Miltenyi Biotec Recent Development
Table 76. Santa Cruz Biotechnology Company Detail
Table 77. Santa Cruz Biotechnology Business Overview
Table 78. Santa Cruz Biotechnology CD86 Antibody Product
Table 79. Santa Cruz Biotechnology Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 80. Santa Cruz Biotechnology Recent Development
Table 81. Bethyl Company Detail
Table 82. Bethyl Business Overview
Table 83. Bethyl CD86 Antibody Product
Table 84. Bethyl Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 85. Bethyl Recent Development
Table 86. United States Biological Company Detail
Table 87. United States Biological Business Overview
Table 88. United States Biological CD86 Antibody Product
Table 89. United States Biological Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 90. United States Biological Recent Development
Table 91. ProSci Company Detail
Table 92. ProSci Business Overview
Table 93. ProSci CD86 Antibody Product
Table 94. ProSci Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 95. ProSci Recent Development
Table 96. Bio X Cell Company Detail
Table 97. Bio X Cell Business Overview
Table 98. Bio X Cell CD86 Antibody Product
Table 99. Bio X Cell Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 100. Bio X Cell Recent Development
Table 101. Beckman Coulter Company Detail
Table 102. Beckman Coulter Business Overview
Table 103. Beckman Coulter CD86 Antibody Product
Table 104. Beckman Coulter Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 105. Beckman Coulter Recent Development
Table 106. NSJ Bioreagents Company Detail
Table 107. NSJ Bioreagents Business Overview
Table 108. NSJ Bioreagents CD86 Antibody Product
Table 109. NSJ Bioreagents Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 110. NSJ Bioreagents Recent Development
Table 111. EXBIO Company Detail
Table 112. EXBIO Business Overview
Table 113. EXBIO CD86 Antibody Product
Table 114. EXBIO Revenue in CD86 Antibody Business (2018-2024) & (US$ Million)
Table 115. EXBIO Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD86 Antibody Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global CD86 Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global CD86 Antibody Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global CD86 Antibody Market Share by Application: 2022 VS 2029
Figure 7. Enzyme Linked Immunosorbent Assay Case Studies
Figure 8. Flow Cytometry Case Studies
Figure 9. Immunohistochemistry Case Studies
Figure 10. Western Blot Case Studies
Figure 11. Others Case Studies
Figure 12. CD86 Antibody Report Years Considered
Figure 13. Global CD86 Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global CD86 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global CD86 Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global CD86 Antibody Market Share by Players in 2022
Figure 17. Global Top CD86 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD86 Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by CD86 Antibody Revenue in 2022
Figure 19. North America CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America CD86 Antibody Market Share by Country (2018-2029)
Figure 21. United States CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe CD86 Antibody Market Share by Country (2018-2029)
Figure 25. Germany CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific CD86 Antibody Market Share by Region (2018-2029)
Figure 33. China CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America CD86 Antibody Market Share by Country (2018-2029)
Figure 41. Mexico CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa CD86 Antibody Market Share by Country (2018-2029)
Figure 45. Turkey CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia CD86 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. BioLegend Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 48. Proteintech Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 50. Bio-Rad Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 51. FineTest Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 52. Miltenyi Biotec Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 53. Santa Cruz Biotechnology Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 54. Bethyl Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 55. United States Biological Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 56. ProSci Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 57. Bio X Cell Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 58. Beckman Coulter Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 59. NSJ Bioreagents Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 60. EXBIO Revenue Growth Rate in CD86 Antibody Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed